No clear answer
Immune reconstitution (cladribine, alemtuzumab, aHSCT): repair myelin in MS (type not specified)
MS (type not specified) · Immune reconstitution (cladribine, alemtuzumab, aHSCT)
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| CLADRI_NET | Phase 4 | 20 | 2023 | Stopped | Not counted: not randomised |
Counted: 0. Will count later: 0. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as No clear answer
Related hypotheses
Assembled by software from public sources.